Cargando…

An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development

Classical type 1 dendritic cells (cDC1s) are required for anti-viral and anti-tumor immunity, which necessitates an understanding of their development. Development of the cDC1 progenitor requires an E protein–dependent enhancer located 41 kilobases downstream of the transcription start site of the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagadia, Prachi, Huang, Xiao, Liu, Tiantian, Durai, Vivek, Grajales-Reyes, Gary E., Nitschke, Maximilian, Modrusan, Zora, Granja, Jeffrey M., Satpathy, Ansuman T., Briseño, Carlos G., Gargaro, Marco, Iwata, Arifumi, Kim, Sunkyung, Chang, Howard Y., Shaw, Andrey S., Murphy, Theresa L., Murphy, Kenneth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707889/
https://www.ncbi.nlm.nih.gov/pubmed/31406377
http://dx.doi.org/10.1038/s41590-019-0449-3
_version_ 1783445924290232320
author Bagadia, Prachi
Huang, Xiao
Liu, Tiantian
Durai, Vivek
Grajales-Reyes, Gary E.
Nitschke, Maximilian
Modrusan, Zora
Granja, Jeffrey M.
Satpathy, Ansuman T.
Briseño, Carlos G.
Gargaro, Marco
Iwata, Arifumi
Kim, Sunkyung
Chang, Howard Y.
Shaw, Andrey S.
Murphy, Theresa L.
Murphy, Kenneth M.
author_facet Bagadia, Prachi
Huang, Xiao
Liu, Tiantian
Durai, Vivek
Grajales-Reyes, Gary E.
Nitschke, Maximilian
Modrusan, Zora
Granja, Jeffrey M.
Satpathy, Ansuman T.
Briseño, Carlos G.
Gargaro, Marco
Iwata, Arifumi
Kim, Sunkyung
Chang, Howard Y.
Shaw, Andrey S.
Murphy, Theresa L.
Murphy, Kenneth M.
author_sort Bagadia, Prachi
collection PubMed
description Classical type 1 dendritic cells (cDC1s) are required for anti-viral and anti-tumor immunity, which necessitates an understanding of their development. Development of the cDC1 progenitor requires an E protein–dependent enhancer located 41 kilobases downstream of the transcription start site of the transcription factor IRF8 (+41 kb Irf8 enhancer) but its maturation instead requires the BATF3-dependent +32 kb Irf8 enhancer. To understand this switch, we performed single-cell RNA sequencing of the common dendritic cell progenitor (CDP) and identified a cluster of cells that expressed transcription factors that influence cDC1 development, such as Nfil3, Id2, and Zeb2. Genetic epistasis among these factors revealed that Nfil3 expression is required for the transition from Zeb2(hi) and Id2(lo) CDPs to Zeb2(lo) and Id2(hi) CDPs, which represent the earliest committed cDC1 progenitors. This genetic circuit blocks E protein activity to exclude plasmacytoid DC potential and explains the switch in Irf8 enhancer usage during cDC1 development.
format Online
Article
Text
id pubmed-6707889
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-67078892020-02-12 An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development Bagadia, Prachi Huang, Xiao Liu, Tiantian Durai, Vivek Grajales-Reyes, Gary E. Nitschke, Maximilian Modrusan, Zora Granja, Jeffrey M. Satpathy, Ansuman T. Briseño, Carlos G. Gargaro, Marco Iwata, Arifumi Kim, Sunkyung Chang, Howard Y. Shaw, Andrey S. Murphy, Theresa L. Murphy, Kenneth M. Nat Immunol Article Classical type 1 dendritic cells (cDC1s) are required for anti-viral and anti-tumor immunity, which necessitates an understanding of their development. Development of the cDC1 progenitor requires an E protein–dependent enhancer located 41 kilobases downstream of the transcription start site of the transcription factor IRF8 (+41 kb Irf8 enhancer) but its maturation instead requires the BATF3-dependent +32 kb Irf8 enhancer. To understand this switch, we performed single-cell RNA sequencing of the common dendritic cell progenitor (CDP) and identified a cluster of cells that expressed transcription factors that influence cDC1 development, such as Nfil3, Id2, and Zeb2. Genetic epistasis among these factors revealed that Nfil3 expression is required for the transition from Zeb2(hi) and Id2(lo) CDPs to Zeb2(lo) and Id2(hi) CDPs, which represent the earliest committed cDC1 progenitors. This genetic circuit blocks E protein activity to exclude plasmacytoid DC potential and explains the switch in Irf8 enhancer usage during cDC1 development. 2019-08-12 2019-09 /pmc/articles/PMC6707889/ /pubmed/31406377 http://dx.doi.org/10.1038/s41590-019-0449-3 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Bagadia, Prachi
Huang, Xiao
Liu, Tiantian
Durai, Vivek
Grajales-Reyes, Gary E.
Nitschke, Maximilian
Modrusan, Zora
Granja, Jeffrey M.
Satpathy, Ansuman T.
Briseño, Carlos G.
Gargaro, Marco
Iwata, Arifumi
Kim, Sunkyung
Chang, Howard Y.
Shaw, Andrey S.
Murphy, Theresa L.
Murphy, Kenneth M.
An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development
title An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development
title_full An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development
title_fullStr An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development
title_full_unstemmed An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development
title_short An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development
title_sort nfil3–zeb2–id2 pathway imposes irf8 enhancer switching during cdc1 development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707889/
https://www.ncbi.nlm.nih.gov/pubmed/31406377
http://dx.doi.org/10.1038/s41590-019-0449-3
work_keys_str_mv AT bagadiaprachi annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT huangxiao annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT liutiantian annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT duraivivek annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT grajalesreyesgarye annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT nitschkemaximilian annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT modrusanzora annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT granjajeffreym annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT satpathyansumant annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT brisenocarlosg annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT gargaromarco annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT iwataarifumi annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT kimsunkyung annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT changhowardy annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT shawandreys annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT murphytheresal annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT murphykennethm annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT bagadiaprachi nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT huangxiao nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT liutiantian nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT duraivivek nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT grajalesreyesgarye nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT nitschkemaximilian nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT modrusanzora nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT granjajeffreym nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT satpathyansumant nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT brisenocarlosg nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT gargaromarco nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT iwataarifumi nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT kimsunkyung nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT changhowardy nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT shawandreys nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT murphytheresal nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development
AT murphykennethm nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development